Author

David A. Constant

Primary ORCID profile (0000-0001-9656-078X · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

David A. ConstantiD3 papers · Oregon Health & Science University

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Bowen Liu· 1 shared Claude Nagamine· 1 shared Jasmine MoshiriiD· 1 shared Karla Kirkegaard· 1 shared Paul Novick· 1 shared Ritika Prasad· 1 shared Roberto MateoiD· 1 shared Steven Kearnes· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Bowen Liu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A targeted computational screen of the SWEETLEAD database reveals FDA-approved compounds with anti-dengue viral activity

Jasmine Moshiri, David A. Constant, Bowen Liu, Roberto Mateo, Steven Kearnes, Paul Novick, Ritika Prasad, Claude Nagamine, Vijay Pande, Karla Kirkegaard

The paper identifies three FDA-approved compounds with anti-dengue activity using computational screening of a safe-in-human database, revealing their potential molecular targets and mechanisms.

mBio · Dec 22, 2020Peer-reviewedMicrobiology